A Win For HTG Molecular Diagnostics, Inc.
Tue, Jul 26, 2022 at 06:58 PM
HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ) soared at $1.22, a gain of 30.1%. On Tue, Jul 26, 2022, HTGM:NASDAQ hit a New 2-Week Intraday Low of $0.92. The stock got featured on our News Catalysts scanner on Tue, Jul 19, 2022 at 08:55 AM in the 'BIOTECH' category. From Tue, Jul 12, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Jul 18, 2022 at $2.08 with a volume of 8M+.
About HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ)
HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.
Top 10 Gainers:
- Ayala Pharmaceuticals, Inc. (AYLA:NASDAQ), 94.25%
- Pagaya Technologies Ltd. (PGY:NASDAQ), 73.11%
- Freight Technologies Inc Com (FRGT:NASDAQ), 67.57%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 60.82%
- InflaRx N.V. (IFRX:NASDAQ), 38.13%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 30.08%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 28.42%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 24.61%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 22.16%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 19.86%